CTRI/2022/09/045278尚未招募3 期
Study of Renal Adverse Effects of Tenofovir Containing Regimen in HIV Infected Children
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.All HIV infected children from age 10 years or weight more than 30 kg to 21 years of age receiving Tenofovir containing ART for at least 6 months
- •2.eGFR more than 60 ml/min/m2
- •3.Individuals whose base line parameters available before starting ART treatment
排除标准
- •1.History of Hypertension, Diabetes Mellitus, Congenital Heart disease, Chronic liver failure, Cardio Vascular Disease, Nephrotic syndrome.
- •2.Hepatitis B and C infection.
- •3.Transfer of care to other medical care facilities
研究者
相似试验
已完成
2 期
Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)covid-19.Covid-19, confirmed cases, positive test resultU07.1IRCT20200422047168N1Ahvaz University of Medical Sciences60
进行中（未招募）
1 期
Vonafexor in Impaired Renal Function and Suspected MASHImpaired renal function and suspected MASHCTIS2023-509192-16-00ENYO Pharma50
已完成
不适用
Renal and Bone Outcome After Switching Tenofovir to Different Antiretroviral StrategiesRenal DiseaseNCT02209740Asociacion para el Estudio de las Enfermedades Infecciosas245
尚未招募
4 期
The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity.;Incidence and reversibility in HBV-monoinfected patients.chronic hepatitis BNL-OMON35281Erasmus MC, Universitair Medisch Centrum Rotterdam180
进行中（未招募）
不适用
The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity in patients with viral liver infection with hepatitis B virus. Incidence and reversibility.Chronic hepatitis BEUCTR2011-004272-11-NLErasmus MC